7-oxo-7,8-dihydro-1,8-naphthyridine-2-carbaldehyde | 959617-00-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 英文名称: 7-oxo-7,8-dihydro-1,8-naphthyridine-2-carbaldehyde
• 英文别名: 7-oxo-8H-1,8-naphthyridine-2-carbaldehyde
• CAS: 959617-00-6
• 化学式: C₉H₆N₂O₂
• 分子量: 174.159
• InChiKey: SPNVSTBHQCEKOL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.4
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  59.1
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  7-oxo-7,8-dihydro-1,8-naphthyridine-2-carbaldehyde 在 palladium 10% on activated carbon 水 、 氢气 、 potassium carbonate 、 溶剂黄146 作用下， 以 甲醇 、 二氯甲烷 、 氯仿 为溶剂， 反应 95.25h， 生成 tert-butyl (1-(2-(7-methoxy-2-oxo-1,5-naphthyridin-1(2H)-yl)ethyl)piperidin-4-yl)((7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)methyl)carbamate
  参考文献：
  名称：

  NOVEL HETEROCYCLIC COMPOUND OR SALT THEREOF AND INTERMEDIATE THEREOF

  摘要：

  公开号：

  EP2022793B1
• 作为产物：
  描述：

  7-methyl-1,8-naphthyridin-2-one 在 5%-palladium/activated carbon selenium(IV) oxide 、 氢气 作用下， 以 1,4-二氧六环 、 乙醇 为溶剂， 反应 257.0h， 生成 7-oxo-7,8-dihydro-1,8-naphthyridine-2-carbaldehyde
  参考文献：
  名称：

  NOVEL HETEROCYCLIC COMPOUND OR SALT THEREOF AND INTERMEDIATE THEREOF

  摘要：

  公开号：

  EP2022793B1

文献信息

• [EN] BRIDGED BICYCLIC COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS<br/>[FR] COMPOSÉS BICYCLIQUES PONTÉS POUR LE TRAITEMENT DES INFECTIONS BACTÉRIENNES
  申请人：KYORIN SEIYAKU KK

  公开号：WO2013003383A1

  公开（公告）日：2013-01-03

  Novel bridged bicyclic compounds are disclosed herein, along with their pharmaceutically acceptable salts, hydrates and prodrugs. Also disclosed are compositions comprising such compounds, methods of preparing such compounds and methods of using such compounds as antibacterial agents. The disclosed compounds, their pharmaceutically acceptable salts, hydrates and prodrugs, as well as compositions comprising such compounds, salts, hydrates and prodrugs, are useful for treating bacterial infections and associated diseases and conditions.

  本文披露了新型桥环双环化合物，以及它们的药用盐、水合物和前药。还披露了包含这些化合物的组合物，制备这些化合物的方法以及将这些化合物用作抗菌剂的方法。所披露的化合物、其药用盐、水合物和前药，以及包含这些化合物、盐、水合物和前药的组合物，可用于治疗细菌感染及相关疾病和症状。
• Heterocyclic compound or salt thereof and intermediate thereof
  申请人：Toyama Chemical Co., Ltd.

  公开号：US08211908B2

  公开（公告）日：2012-07-03

  Disclosed is a compound represented by the general formula: [wherein R1 represents an aryl or heterocyclic group which may be substituted or the like; X1 represents a C2-C4 alkylene group or the like; X2, X3 and X5 independently represent NH, a bond or the like; X4 represents a lower alkylene group, a bond or the like; Y1 represents a bivalent alicyclic hydrocarbon residue which may be substituted or a bivalent alicyclic amine residue which may be substituted; and Z1, Z2, Z3, Z4, Z5 and Z6 independently represent a nitrogen atom, a group represented by the formula: CH, or the like, provided that at least one of Z3, Z4, Z5 and Z6 represents a nitrogen atom] or a salt thereof, which is useful as an antibacterial agent.

  本发明涉及一种化合物，其通式表示为：[其中R1表示取代的芳基或杂环基等; X1表示C2-C4烷基或类似物; X2、X3和X5独立地表示NH，键或类似物; X4表示较低的烷基或键或类似物; Y1表示可以被取代的二价脂环烃残基或二价脂环胺基残基; Z1、Z2、Z3、Z4、Z5和Z6独立地表示氮原子、由公式CH表示的基团或类似物，但至少有一个Z3、Z4、Z5和Z6表示氮原子]或其盐，其作为一种抗菌剂是有用的。
• BRIDGED BICYCLIC COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS
  申请人：Fukuda Yasumichi

  公开号：US20140243302A1

  公开（公告）日：2014-08-28

  Novel bridged bicyclic compounds are disclosed herein, along with their pharmaceutically acceptable salts, hydrates and prodrugs. Also disclosed are compositions comprising such compounds, methods of preparing such compounds and methods of using such compounds as antibacterial agents. The disclosed compounds, their pharmaceutically acceptable salts, hydrates and prodrugs, as well as compositions comprising such compounds, salts, hydrates and prodrugs, are useful for treating bacterial infections and associated diseases and conditions.

  本文披露了新型桥环双环化合物及其药学上可接受的盐、水合物和前药。还披露了包含这些化合物的组合物、制备这些化合物的方法以及将这些化合物用作抗菌剂的方法。披露的化合物、它们的药学上可接受的盐、水合物和前药，以及包含这些化合物、盐、水合物和前药的组合物，可用于治疗细菌感染及相关疾病和病情。
• US8211908B2
  申请人：——

  公开号：US8211908B2

  公开（公告）日：2012-07-03
• US8367831B2
  申请人：——

  公开号：US8367831B2

  公开（公告）日：2013-02-05